229 related articles for article (PubMed ID: 28987514)
1. Analysis of PTPRK polymorphisms in association with risk and age at onset of Alzheimer's disease, cancer risk, and cholesterol.
Chen Y; Xu C; Harirforoosh S; Luo X; Wang KS
J Psychiatr Res; 2018 Jan; 96():65-72. PubMed ID: 28987514
[TBL] [Abstract][Full Text] [Related]
2. Non-parametric Survival Analysis of EPG5 Gene with Age at Onset of Alzheimer's Disease.
Wang KS; Liu X; Xie C; Liu Y; Xu C
J Mol Neurosci; 2016 Dec; 60(4):436-444. PubMed ID: 27586004
[TBL] [Abstract][Full Text] [Related]
3. Family-based association analysis of NAV2 gene with the risk and age at onset of Alzheimer's disease.
Wang KS; Liu Y; Xu C; Liu X; Luo X
J Neuroimmunol; 2017 Sep; 310():60-65. PubMed ID: 28778446
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms within ASTN2 gene are associated with age at onset of Alzheimer's disease.
Wang KS; Tonarelli S; Luo X; Wang L; Su B; Zuo L; Mao C; Rubin L; Briones D; Xu C
J Neural Transm (Vienna); 2015 May; 122(5):701-8. PubMed ID: 25410587
[TBL] [Abstract][Full Text] [Related]
5. NRG3 gene is associated with the risk and age at onset of Alzheimer disease.
Wang KS; Xu N; Wang L; Aragon L; Ciubuc R; Arana TB; Mao C; Petty L; Briones D; Su BB; Luo X; Camarillo C; Escamilla MA; Xu C
J Neural Transm (Vienna); 2014 Feb; 121(2):183-92. PubMed ID: 24061483
[TBL] [Abstract][Full Text] [Related]
6. Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
Herold C; Hooli BV; Mullin K; Liu T; Roehr JT; Mattheisen M; Parrado AR; Bertram L; Lange C; Tanzi RE
Mol Psychiatry; 2016 Nov; 21(11):1608-1612. PubMed ID: 26830138
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms Within RYR3 Gene Are Associated With Risk and Age at Onset of Hypertension, Diabetes, and Alzheimer's Disease.
Gong S; Su BB; Tovar H; Mao C; Gonzalez V; Liu Y; Lu Y; Wang KS; Xu C
Am J Hypertens; 2018 Jun; 31(7):818-826. PubMed ID: 29590321
[TBL] [Abstract][Full Text] [Related]
8. Bayesian Cox Proportional Hazards Model in Survival Analysis of HACE1 Gene with Age at Onset of Alzheimer's Disease.
Wang KS; Liu Y; Gong S; Xu C; Xie X; Wang L; Luo X
Int J Clin Biostat Biom; 2017; 3(1):. PubMed ID: 29430571
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association analysis of age-at-onset in Alzheimer's disease.
Kamboh MI; Barmada MM; Demirci FY; Minster RL; Carrasquillo MM; Pankratz VS; Younkin SG; Saykin AJ; ; Sweet RA; Feingold E; DeKosky ST; Lopez OL
Mol Psychiatry; 2012 Dec; 17(12):1340-6. PubMed ID: 22005931
[TBL] [Abstract][Full Text] [Related]
10. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.
Naj AC; Jun G; Reitz C; Kunkle BW; Perry W; Park YS; Beecham GW; Rajbhandary RA; Hamilton-Nelson KL; Wang LS; Kauwe JS; Huentelman MJ; Myers AJ; Bird TD; Boeve BF; Baldwin CT; Jarvik GP; Crane PK; Rogaeva E; Barmada MM; Demirci FY; Cruchaga C; Kramer PL; Ertekin-Taner N; Hardy J; Graff-Radford NR; Green RC; Larson EB; St George-Hyslop PH; Buxbaum JD; Evans DA; Schneider JA; Lunetta KL; Kamboh MI; Saykin AJ; Reiman EM; De Jager PL; Bennett DA; Morris JC; Montine TJ; Goate AM; Blacker D; Tsuang DW; Hakonarson H; Kukull WA; Foroud TM; Martin ER; Haines JL; Mayeux RP; Farrer LA; Schellenberg GD; Pericak-Vance MA; ; Albert MS; Albin RL; Apostolova LG; Arnold SE; Barber R; Barnes LL; Beach TG; Becker JT; Beekly D; Bigio EH; Bowen JD; Boxer A; Burke JR; Cairns NJ; Cantwell LB; Cao C; Carlson CS; Carney RM; Carrasquillo MM; Carroll SL; Chui HC; Clark DG; Corneveaux J; Cribbs DH; Crocco EA; DeCarli C; DeKosky ST; Dick M; Dickson DW; Duara R; Faber KM; Fallon KB; Farlow MR; Ferris S; Frosch MP; Galasko DR; Ganguli M; Gearing M; Geschwind DH; Ghetti B; Gilbert JR; Glass JD; Growdon JH; Hamilton RL; Harrell LE; Head E; Honig LS; Hulette CM; Hyman BT; Jicha GA; Jin LW; Karydas A; Kaye JA; Kim R; Koo EH; Kowall NW; Kramer JH; LaFerla FM; Lah JJ; Leverenz JB; Levey AI; Li G; Lieberman AP; Lin CF; Lopez OL; Lyketsos CG; Mack WJ; Martiniuk F; Mash DC; Masliah E; McCormick WC; McCurry SM; McDavid AN; McKee AC; Mesulam M; Miller BL; Miller CA; Miller JW; Murrell JR; Olichney JM; Pankratz VS; Parisi JE; Paulson HL; Peskind E; Petersen RC; Pierce A; Poon WW; Potter H; Quinn JF; Raj A; Raskind M; Reisberg B; Ringman JM; Roberson ED; Rosen HJ; Rosenberg RN; Sano M; Schneider LS; Seeley WW; Smith AG; Sonnen JA; Spina S; Stern RA; Tanzi RE; Thornton-Wells TA; Trojanowski JQ; Troncoso JC; Valladares O; Van Deerlin VM; Van Eldik LJ; Vardarajan BN; Vinters HV; Vonsattel JP; Weintraub S; Welsh-Bohmer KA; Williamson J; Wishnek S; Woltjer RL; Wright CB; Younkin SG; Yu CE; Yu L
JAMA Neurol; 2014 Nov; 71(11):1394-404. PubMed ID: 25199842
[TBL] [Abstract][Full Text] [Related]
11. Polygenic risk and hazard scores for Alzheimer's disease prediction.
Leonenko G; Sims R; Shoai M; Frizzati A; Bossù P; Spalletta G; Fox NC; Williams J; ; Hardy J; Escott-Price V
Ann Clin Transl Neurol; 2019 Mar; 6(3):456-465. PubMed ID: 30911569
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease.
Ozturk A; DeKosky ST; Kamboh MI
Neurobiol Aging; 2006 Oct; 27(10):1440-4. PubMed ID: 16223550
[TBL] [Abstract][Full Text] [Related]
14. Family-based genome scan for age at onset of late-onset Alzheimer's disease in whole exome sequencing data.
Saad M; Brkanac Z; Wijsman EM
Genes Brain Behav; 2015 Nov; 14(8):607-17. PubMed ID: 26394601
[TBL] [Abstract][Full Text] [Related]
15. ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease.
Macé S; Cousin E; Ricard S; Génin E; Spanakis E; Lafargue-Soubigou C; Génin B; Fournel R; Roche S; Haussy G; Massey F; Soubigou S; Bréfort G; Benoit P; Brice A; Campion D; Hollis M; Pradier L; Benavides J; Deleuze JF
Neurobiol Dis; 2005 Feb; 18(1):119-25. PubMed ID: 15649702
[TBL] [Abstract][Full Text] [Related]
16. Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.
Hao K; Di Narzo AF; Ho L; Luo W; Li S; Chen R; Li T; Dubner L; Pasinetti GM
Mol Aspects Med; 2015; 43-44():66-76. PubMed ID: 26116273
[TBL] [Abstract][Full Text] [Related]
17. PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
Belbin O; Beaumont H; Warden D; Smith AD; Kalsheker N; Morgan K
Neurobiol Aging; 2009 Dec; 30(12):1992-9. PubMed ID: 18403054
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide significant, replicated and functional risk variants for Alzheimer's disease.
Guo X; Qiu W; Garcia-Milian R; Lin X; Zhang Y; Cao Y; Tan Y; Wang Z; Shi J; Wang J; Liu D; Song L; Xu Y; Wang X; Liu N; Sun T; Zheng J; Luo J; Zhang H; Xu J; Kang L; Ma C; Wang K; Luo X
J Neural Transm (Vienna); 2017 Nov; 124(11):1455-1471. PubMed ID: 28770390
[TBL] [Abstract][Full Text] [Related]
19. Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures.
Kamboh MI; Minster RL; Feingold E; DeKosky ST
Mol Psychiatry; 2006 Mar; 11(3):273-9. PubMed ID: 16302009
[TBL] [Abstract][Full Text] [Related]
20. Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease.
Kamboh MI; Minster RL; Kenney M; Ozturk A; Desai PP; Kammerer CM; DeKosky ST
Neurobiol Aging; 2006 Oct; 27(10):1435-9. PubMed ID: 16137793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
